Registration

COVINGTON & BURLING LLP for AMARIN PHARMA INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

PDUFA: FDA special protocol assessment agreement process.

LobbyistCovered position, as disclosed
JOAN KUTCHER New —
MUFTIAH MCCARTIN New House Rules Committee, Staff Director (2009- ; ; 2010); House Rules Committee, Deputy Staff ; ; (Assistant 1991-2005); Clerk
WILLIAM WICHTERMAN New Special Ass't to President Bush and Deputy Dir. ; ; Deputy Staff Director (2007-2008); House of

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
AMARIN CORPORATION, PLC Ireland United States 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.